Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -56.74 is 95% above its 5-year average of -1128.94, near the high end of its 5-year range (-4133.60–-7.84).
312.35% below its 12-month average of -13.76.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): -52.54.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
EARNINGS PER SHARE (EPS)
-56.74
EARNINGS PER SHARE (EPS) AVG TTM
-13.76
EARNINGS PER SHARE (EPS) AVG 3Y
-493.08
EARNINGS PER SHARE (EPS) AVG 5Y
-1128.94
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-312.35%
CURRENT VS 3Y AVG
+88.49%
CURRENT VS 5Y AVG
+94.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Valion Bio, Inc.
Market Cap
$9.86M
Earnings Per Share (EPS)
-56.74
TTM Avg
-13.76
3Y Avg
-493.08
5Y Avg
-1128.94
Market Cap
$9.83M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.65
3Y Avg
-2.75
5Y Avg
-5.28
Market Cap
$9.75M
Earnings Per Share (EPS)
-4.07
TTM Avg
-23.25
3Y Avg
-137.85
5Y Avg
-1187.50
Market Cap
$9.71M
Earnings Per Share (EPS)
-1.92
TTM Avg
-10.95
3Y Avg
-6.49
5Y Avg
-5.26
Market Cap
$10.06M
Earnings Per Share (EPS)
-1.62
TTM Avg
-1.32
3Y Avg
-0.82
5Y Avg
-0.71
Market Cap
$10.06M
Earnings Per Share (EPS)
-1.77
TTM Avg
-11.49
3Y Avg
-12.47
5Y Avg
-11.51
Market Cap
$10.13M
Earnings Per Share (EPS)
-2.79
TTM Avg
-24.53
3Y Avg
-24.53
5Y Avg
-26.36
Market Cap
$9.50M
Earnings Per Share (EPS)
-2.52
TTM Avg
-2.51
3Y Avg
-3.38
5Y Avg
-3.13
Market Cap
$10.21M
Earnings Per Share (EPS)
-16.82
TTM Avg
-28.56
3Y Avg
-28.65
5Y Avg
-34.30
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Valion Bio, Inc. (VBIO) | $9.86M | -56.74 | -13.76 | -493.08 | -1128.94 |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -0.91 | -1.65 | -2.75 | -5.28 |
| MetaVia Inc. (MTVA)vs › | $9.75M | -4.07 | -23.25 | -137.85 | -1187.50 |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | -1.92 | -10.95 | -6.49 | -5.26 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -1.62 | -1.32 | -0.82 | -0.71 |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | -1.77 | -11.49 | -12.47 | -11.51 |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | -2.79 | -24.53 | -24.53 | -26.36 |
| Ainos, Inc. (AIMD)vs › | $9.50M | -2.52 | -2.51 | -3.38 | -3.13 |
| Lifeward Ltd. (LFWD)vs › | $10.21M | -16.82 | -28.56 | -28.65 | -34.30 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | -16.53 | -14.84 | -116.30 | -277.16 |
Trailing EPS (TTM)
$-56.74
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -7.84 |
| 2024-12-31 | -19.68 |
| 2023-12-31 | -176.80 |
| 2022-12-31 | -1768.00 |
| 2021-12-31 | -4133.60 |
| 2020-12-31 | -667.69 |
| 2019-12-31 | -761.09 |
